Free Trial

AdvanSix (NYSE:ASIX) Trading 6.8% Higher - Here's Why

AdvanSix logo with Basic Materials background

AdvanSix Inc. (NYSE:ASIX - Get Free Report)'s stock price traded up 6.8% during trading on Monday . The stock traded as high as $28.48 and last traded at $28.30. 31,973 shares changed hands during trading, a decline of 72% from the average session volume of 114,684 shares. The stock had previously closed at $26.50.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the company. StockNews.com upgraded AdvanSix from a "hold" rating to a "buy" rating in a research note on Wednesday, December 4th. Piper Sandler increased their target price on AdvanSix from $35.00 to $39.00 and gave the company an "overweight" rating in a research note on Friday, November 8th.

View Our Latest Stock Analysis on AdvanSix

AdvanSix Trading Up 9.5 %

The company has a current ratio of 1.34, a quick ratio of 0.62 and a debt-to-equity ratio of 0.28. The business has a 50 day simple moving average of $29.93 and a two-hundred day simple moving average of $28.57. The stock has a market cap of $776.00 million, a price-to-earnings ratio of 20.59 and a beta of 1.76.

AdvanSix Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Tuesday, November 12th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.20%. The ex-dividend date of this dividend was Tuesday, November 12th. AdvanSix's dividend payout ratio is presently 45.39%.

Insiders Place Their Bets

In other AdvanSix news, CEO Erin N. Kane sold 5,000 shares of AdvanSix stock in a transaction on Friday, November 1st. The stock was sold at an average price of $30.37, for a total transaction of $151,850.00. Following the sale, the chief executive officer now owns 517,795 shares of the company's stock, valued at $15,725,434.15. The trade was a 0.96 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Christopher Gramm sold 2,435 shares of AdvanSix stock in a transaction on Wednesday, November 6th. The shares were sold at an average price of $32.00, for a total value of $77,920.00. Following the sale, the insider now directly owns 43,463 shares in the company, valued at $1,390,816. The trade was a 5.31 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 14,749 shares of company stock valued at $444,205 in the last quarter. Insiders own 5.60% of the company's stock.

Institutional Trading of AdvanSix

Hedge funds have recently added to or reduced their stakes in the business. Point72 DIFC Ltd acquired a new position in shares of AdvanSix during the 2nd quarter valued at $34,000. Acadian Asset Management LLC acquired a new position in shares of AdvanSix in the 2nd quarter worth $36,000. Copeland Capital Management LLC acquired a new position in shares of AdvanSix in the 3rd quarter worth $41,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of AdvanSix in the 2nd quarter worth $51,000. Finally, Point72 Asset Management L.P. acquired a new position in shares of AdvanSix in the 2nd quarter worth $55,000. Institutional investors own 86.39% of the company's stock.

AdvanSix Company Profile

(Get Free Report)

AdvanSix Inc engages in the manufacture and sale of polymer resins in the United States and internationally. It offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. The company also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and engineered plastic resins, as well as other intermediate chemicals, including phenol, monoisopropylamine, dipropylamine, monoallylamine, alpha-methylstyrene, cyclohexanone, methyl ethyl ketoxime, acetaldehyde oxime, 2-pentanone oxime, cyclohexanol, sulfuric acid, ammonia, and carbon dioxide.

Further Reading

Should You Invest $1,000 in AdvanSix Right Now?

Before you consider AdvanSix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AdvanSix wasn't on the list.

While AdvanSix currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks
7 Stocks to Benefit From Trump’s Tariffs in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines